Department of Radiation Oncology, University of Lubeck, Lubeck, Germany.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e861-8. doi: 10.1016/j.ijrobp.2010.11.056. Epub 2011 Jan 27.
Despite a previously published randomized trial, controversy exists regarding the benefit of adding surgery to radiotherapy for metastatic spinal cord compression (MSCC). It is thought that patients with MSCC from relatively radioresistant tumors or tumors associated with poor functional outcome after radiotherapy alone may benefit from surgery. This study focuses on these tumors.
Data from 67 patients receiving surgery plus radiotherapy (S+RT) were matched to 134 patients (1:2) receiving radiotherapy alone (RT). Groups were matched for 10 factors and compared for motor function, ambulatory status, local control, and survival. Additional separate matched-pair analyses were performed for patients receiving direct decompressive surgery plus stabilization of involved vertebrae (DDSS) and patients receiving laminectomy (LE).
Improvement of motor function occurred in 22% of patients after S+RT and 16% after RT (p=0.25). Posttreatment ambulatory rates were 67% and 61%, respectively (p=0.68). Of nonambulatory patients, 29% and 19% (p=0.53) regained ambulatory status. One-year local control rates were 85% and 89% (p=0.87). One-year survival rates were 38% and 24% (p=0.20). The matched-pair analysis of patients receiving LE showed no significant differences between both therapies. In the matched-pair analysis of patients receiving DDSS, improvement of motor function occurred more often after DDSS+RT than RT (28% vs. 19%, p=0.024). Posttreatment ambulatory rates were 86% and 67% (p=0.30); 45% and 18% of patients regained ambulatory status (p=0.29).
Patients with MSCC from an unfavorable primary tumor appeared to benefit from DDSS but not LE when added to radiotherapy in terms of improved functional outcome.
尽管之前发表过一项随机试验,但对于放射治疗联合手术治疗转移性脊髓压迫症(MSCC)的益处仍存在争议。人们认为,来自相对放射抗拒性肿瘤或单独接受放射治疗后功能预后较差的肿瘤的 MSCC 患者可能会从手术中受益。本研究重点关注这些肿瘤。
对 67 例接受手术联合放疗(S+RT)的患者的数据进行了匹配,共匹配了 134 例(1:2)单独接受放疗(RT)的患者。两组患者按 10 个因素进行匹配,并比较运动功能、活动状态、局部控制和生存情况。还对接受直接减压手术加受累脊柱稳定术(DDSS)和接受椎板切除术(LE)的患者进行了单独的配对分析。
S+RT 治疗后患者运动功能改善的比例为 22%,RT 治疗后为 16%(p=0.25)。治疗后可活动的患者比例分别为 67%和 61%(p=0.68)。非活动患者中,分别有 29%和 19%(p=0.53)恢复了活动能力。1 年局部控制率分别为 85%和 89%(p=0.87)。1 年生存率分别为 38%和 24%(p=0.20)。LE 治疗患者的配对分析显示两种治疗方法之间无显著差异。DDSS 治疗患者的配对分析显示,DDSS+RT 治疗后运动功能改善的比例高于 RT(28%比 19%,p=0.024)。治疗后可活动的患者比例分别为 86%和 67%(p=0.30);分别有 45%和 18%的患者恢复了活动能力(p=0.29)。
在原发性肿瘤预后不良的 MSCC 患者中,与单独接受放射治疗相比,当将 DDSS 联合放射治疗时,患者的功能预后得到改善。